Starlims has established Starlims Europe as a result of the May 2008 acquisition of its long-time UK partner and hired LIMS veteran Joe Peden as general manager of the new subsidiary.
Neil Kipling, founder and CEO of IDBS, has been awarded an honorary doctorate (DUniv) from the University of Surrey.
Accelerated Technology Laboratories (ATL) has promoted Fred Rider to the position of director of support services.
Interactive Supercomputing (ISC) has appointed ISC board member, Bill Strecker, as its chief technology officer (CTO), while former AMD HPC marketing director David Rich has joined as vice president of marketing.
Linguamatics has expanded into Delaware, USA and appointed Susan LeBeau as director of North American Sales.
KineMatik has appointed Dr Aaron Norman as vice president of implementation and services. Dr Norman will report directly to Thomas Cassidy, CEO of KineMatik.
Symyx Technologies has promoted Trevor Heritage to president of Symyx Software.
Surak Perera joins Adept having recently completed a MEng in Aerospace at Southampton University.
ChemAxon has appointed Alex Drijver as CEO. The arrival signals the company's increased focus on business development and market position. Ferenc Csizmadia, founder and former CEO, moves to chairman and head of Research and Development.
Dr John William Poduska has joined Interactive Supercomputing Inc.s (ISC) board of directors.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
